Company / Cash per Share
Edesa Biotech, Inc. Cash per Share History
FY2014-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.75
FY2021
5-year range
$0.67 / $3.04
FY2017-FY2021
Trend
+11.9%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 7 years, ranging from $0.02 in FY2014 to $3.04 in FY2018.
Based on SEC 10-K filings.
0.75 in FY2021 with a 5-year CAGR of -5.3%.
Declined from $3.04 to $0.75 over the past 3 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -37.3%
- 5-Year CAGR
- -5.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, cash per share increased 11.9% year-over-year.
- Peak cash per share was recorded in FY2018.
- Lowest cash per share in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $0.75 | +11.9% |
| FY2020 | $0.67 | -78.0% |
| FY2018 | $3.04 | +315.7% |
| FY2017 | $0.73 | -25.7% |
| FY2016 | $0.98 | -2.0% |
| FY2015 | $1.00 | +5724.9% |
| FY2014 | $0.02 | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026